Eduardo L Setti
age ~68
from Fremont, CA
- Also known as:
-
- Eduardo E Setti
- Phone and address:
-
320 Paloma Ter, Fremont, CA 94536
650 303-1579
Eduardo Setti Phones & Addresses
- 320 Paloma Ter, Fremont, CA 94536 • 650 303-1579
- 804 Delaware St, San Mateo, CA 94401 • 650 579-2718
- 202 High St, Nutley, NJ 07110 • 973 284-1874
- 320 Paloma Ter, Fremont, CA 94536 • 510 754-3648
Work
-
Position:Professional/Technical
Education
-
Degree:Graduate or professional degree
Industries
Biotechnology
Resumes
Us Patents
-
Compounds And Compositions As Protease Inhibitors
view source -
US Patent:6476026, Nov 5, 2002
-
Filed:Mar 15, 2000
-
Appl. No.:09/526485
-
Inventors:Clifford M. Bryant - Millbrae CA
James T. Palmer - Corte Madera CA
Robert M. Rydzewski - Newark CA
Eduardo L. Setti - San Mateo CA
Shankar Venkatraman - Foster City CA
Dan-Xiong Wang - Foster City CA -
Assignee:Axys Pharmaceuticals, Inc. - So. San Francisco CA
-
International Classification:A61K 314439
-
US Classification:5142358, 5142368, 51425402, 514326, 514331, 514342, 514428, 544121, 544133, 544209, 544360, 544370, 546224, 5462704, 5462707, 548571
-
Abstract:The present invention relates to novel N-cyanomethyl amides which are cysteine protease inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.
-
Compounds And Compositions As Protease Inhibitors
view source -
US Patent:6525036, Feb 25, 2003
-
Filed:Jan 5, 2001
-
Appl. No.:09/754962
-
Inventors:Renata Marcella Oballa - Kirkland, CA
Petpiboon Prasit - Pierrefonds, CA
Joel Stephane Robichaud - Dollard des Ormeaux, CA
Elise Isabel - Pointe-Claire, CA
Eduardo Setti - San Mateo CA
Dan-Xiong Wang - Foster City CA
Rohan V. Mendonca - South San Francisco CA
Shankar Venkatraman - Pleasanton CA -
Assignee:Merck Co., Inc. - Rahway NJ
-
International Classification:A61K 31277
-
US Classification:514112, 514521, 5142385, 514352, 514357, 544168, 544336, 544344, 544366, 544389, 544393, 544400, 546 17, 546133, 546175, 546231, 546330, 548214, 548253, 5483361, 548455, 548484, 558384, 558386, 558392
-
Abstract:The present invention relates to novel cysteine protease inhibitors of Formula I: the pharmaceutically acceptable salts and N-oxide derivatives thereof, their use as therapeutic agents and methods of making them.
-
Compounds And Compositions As Protease Inhibitors
view source -
US Patent:6593327, Jul 15, 2003
-
Filed:Dec 14, 2001
-
Appl. No.:10/017851
-
Inventors:Clifford M. Bryant - Millbrae CA
James T. Palmer - Corte Madera CA
Robert M. Rydzewski - Newark CA
Eduardo L. Setti - San Mateo CA
Shankar Venkatraman - Foster City CA
Dan-Xiong Wang - Foster City CA -
Assignee:Axys Pharmaceuticals, Inc. - South San Francisco CA
-
International Classification:A61K 314439
-
US Classification:5142358, 51425402, 514326, 514342, 544121, 544133, 544360, 544369, 544372, 544390, 546209, 5462704, 5462707, 548194
-
Abstract:The present invention relates to novel N-cyanomethyl amides which are cysteine protease inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.
-
Cathepsin Cysteine Protease Inhibitors
view source -
US Patent:7012075, Mar 14, 2006
-
Filed:Mar 1, 2002
-
Appl. No.:10/469430
-
Inventors:Christopher Ian Bayly - Beaconsfield, CA
Joel Stephane Robichaud - Dollard des Ormeaux, CA
W. Cameron Black - Baie d'Urfe, CA
Eduardo L. Setti - San Mateo CA, US
Robert M. Rydzewski - Newark CA, US
James T. Palmer - Corte Madera CA, US -
Assignee:Merck & Co., Inc. - Rahway NJ
Axys Pharmaceuticals, Inc. - South San Francisco CA -
International Classification:A61K 31/495
A61K 31/44
A61K 31/275
C07D 413/00
C07C 255/00 -
US Classification:51425213, 514336, 514520, 514521, 544369, 558388, 558392, 5462681
-
Abstract:This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.
-
Hydroxamates As Therapeutic Agents
view source -
US Patent:7368476, May 6, 2008
-
Filed:Apr 7, 2005
-
Appl. No.:11/100781
-
Inventors:Eduardo L. Setti - San Mateo CA, US
-
Assignee:Pharmacyclics, Inc. - Sunnyvale CA
-
International Classification:A61K 31/34
C07D 307/00 -
US Classification:514469, 514320, 514337, 549469, 546196, 546205, 5462841
-
Abstract:The present invention is directed to certain hydroxamate derivatives that are inhibitors of histone deacetylase and are therefore useful in the treatment of diseases associated with histone deacetylase activity. Pharmaceutical compositions and processes for preparing these compounds are also disclosed.
-
Cyanoalkylamino Derivatives As Protease Inhibitors
view source -
US Patent:7371747, May 13, 2008
-
Filed:Nov 13, 2002
-
Appl. No.:10/495387
-
Inventors:Cameron Black - Baie d'Urfe, CA
Sheldon N. Crane - Rue D'Amalfi, CA
Dana Davis - Santa Clara CA, US
Eduardo L. Setti - San Mateo CA, US -
Assignee:Merck Frosst Canada & Co. - Quebec
-
International Classification:A61K 31/535
-
US Classification:5142315, 51425213, 514277, 514449, 514520, 544158, 544159, 544383, 544392, 544393, 546262, 546265, 549491, 558190, 558391, 558392, 558436, 558445
-
Abstract:The present invention is directed to novel cyanoalkylamino derivatives that are inhibitors of cysteine protease such as cathepsins K, S, B and L, in particular cathepsin K Pharmaceutical composition comprising these compounds, method of treating diseases mediated by unregulated cysteine protease activity, in particular cathepsin K utilizing these compounds and methods of preparing these compounds are also disclosed.
-
Haloalkyl Containing Compounds As Cysteine Protease Inhibitors
view source -
US Patent:8013186, Sep 6, 2011
-
Filed:Dec 1, 2005
-
Appl. No.:11/791928
-
Inventors:Eduardo L. Setti - San Mateo CA, US
-
Assignee:Virobay, Inc. - Menlo Park CA
-
International Classification:C07C 233/00
A01N 37/18 -
US Classification:564123, 514617
-
Abstract:The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.
-
Jak Kinase Modulating Compounds And Methods Of Use Thereof
view source -
US Patent:8349851, Jan 8, 2013
-
Filed:Feb 26, 2010
-
Appl. No.:12/714323
-
Inventors:Sunny Abraham - San Diego CA, US
Qi Chao - San Diego CA, US
Michael J. Hadd - San Diego CA, US
Mark W. Holladay - San Diego CA, US
Gang Liu - San Diego CA, US
Eduardo Setti - San Mateo CA, US -
Assignee:Ambit Biosciences Corp. - San Diego CA
-
International Classification:A61K 31/517
-
US Classification:51426623, 544284
-
Abstract:Provided herein are quinazoline compounds of formula (I):.
Eduardo Setti
view sourceFriends:
Felipe Sampaio Ceccarelli, Lucia De Castro Ferreira, Bernardo Saraiva
Lus Eduardo Setti Padin
view sourceFriends:
Carolina Coltro, Robi Marcondes, Guilherme Tuccille Braga
Eduardo Setti
view sourceFriends:
Jenny Ho, Camila Esteves, Larissa Waihrich, Saad Ali, Juan Pablo Lingua
Eduardo Setti
view sourceGoogleplus
Eduardo Setti
Eduardo Setti
Plaxo
Eduardo Setti
view sourceSão Bernanrdo do Campo - SP - Brasil
Plaxo > Setters J Settl...
view sourceSetthachayanon, N Setthasawet, W; Setti, An Setti, Ar; Setti, b Setti, D; Setti, Eduardo Setti, Eduardo A; Setti, E Setti, F
Eduardo Setti
view sourcePast: Gerente at Novo Cruzeiro, Gerente at Novo Cruzeiro
Classmates
Okmulgee High School Okmu...
view source3,272 alumni are already here! Your fellow graduates have uploaded 270 pictures and ... Eduardo Setti
Eduardo Setti
view sourceSchools:
Okmulgee High School Okmulgee OK 1993-1997
Community:
Crystal Lansdale, Tiesha Giles, Garland Reid, Cammie Robinson, Maurice Furch, Rebecca Carder, Amanda Chambers, Alicia Veltri
Myspace
Youtube
Get Report for Eduardo L Setti from Fremont, CA, age ~68